nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—stomach cancer—esophageal cancer	0.379	0.517	CtDrD
Epirubicin—pancreatic cancer—esophageal cancer	0.353	0.483	CtDrD
Epirubicin—CHD1—bronchus—esophageal cancer	0.00275	0.0719	CbGeAlD
Epirubicin—CHD1—trachea—esophageal cancer	0.00247	0.0646	CbGeAlD
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—esophageal cancer	0.00239	1	CbGdCrCtD
Epirubicin—DHCR7—bronchus—esophageal cancer	0.00185	0.0485	CbGeAlD
Epirubicin—CHD1—lung—esophageal cancer	0.00177	0.0464	CbGeAlD
Epirubicin—AURKA—digestive system—esophageal cancer	0.00171	0.0448	CbGeAlD
Epirubicin—YWHAG—bronchus—esophageal cancer	0.0017	0.0445	CbGeAlD
Epirubicin—DHCR7—trachea—esophageal cancer	0.00166	0.0435	CbGeAlD
Epirubicin—YWHAG—smooth muscle tissue—esophageal cancer	0.00166	0.0435	CbGeAlD
Epirubicin—YWHAG—trachea—esophageal cancer	0.00153	0.0399	CbGeAlD
Epirubicin—DHCR7—digestive system—esophageal cancer	0.00143	0.0375	CbGeAlD
Epirubicin—AURKA—lung—esophageal cancer	0.00143	0.0374	CbGeAlD
Epirubicin—YWHAG—digestive system—esophageal cancer	0.00131	0.0344	CbGeAlD
Epirubicin—PLA2G4A—bronchus—esophageal cancer	0.00127	0.0332	CbGeAlD
Epirubicin—PLA2G4A—smooth muscle tissue—esophageal cancer	0.00124	0.0325	CbGeAlD
Epirubicin—CHD1—lymph node—esophageal cancer	0.00121	0.0317	CbGeAlD
Epirubicin—TOP2A—bronchus—esophageal cancer	0.0012	0.0315	CbGeAlD
Epirubicin—DHCR7—lung—esophageal cancer	0.00119	0.0313	CbGeAlD
Epirubicin—UGT2B7—digestive system—esophageal cancer	0.00119	0.031	CbGeAlD
Epirubicin—PLA2G4A—trachea—esophageal cancer	0.00114	0.0298	CbGeAlD
Epirubicin—YWHAG—lung—esophageal cancer	0.0011	0.0287	CbGeAlD
Epirubicin—AURKA—lymph node—esophageal cancer	0.000977	0.0256	CbGeAlD
Epirubicin—PLA2G4A—lung—esophageal cancer	0.000818	0.0214	CbGeAlD
Epirubicin—DHCR7—lymph node—esophageal cancer	0.000817	0.0214	CbGeAlD
Epirubicin—TOP2A—lung—esophageal cancer	0.000777	0.0203	CbGeAlD
Epirubicin—YWHAG—lymph node—esophageal cancer	0.00075	0.0196	CbGeAlD
Epirubicin—ABCC1—bronchus—esophageal cancer	0.000725	0.019	CbGeAlD
Epirubicin—Daunorubicin—CYP1B1—esophageal cancer	0.000695	0.176	CrCbGaD
Epirubicin—Doxorubicin—NOS3—esophageal cancer	0.000687	0.174	CrCbGaD
Epirubicin—Doxorubicin—NOS2—esophageal cancer	0.000664	0.168	CrCbGaD
Epirubicin—ABCC1—trachea—esophageal cancer	0.000651	0.017	CbGeAlD
Epirubicin—Doxorubicin—CYP1B1—esophageal cancer	0.000564	0.143	CrCbGaD
Epirubicin—PLA2G4A—lymph node—esophageal cancer	0.000559	0.0146	CbGeAlD
Epirubicin—Daunorubicin—ABCC2—esophageal cancer	0.000542	0.137	CrCbGaD
Epirubicin—TOP2A—lymph node—esophageal cancer	0.000531	0.0139	CbGeAlD
Epirubicin—ABCC1—lung—esophageal cancer	0.000468	0.0122	CbGeAlD
Epirubicin—Doxorubicin—ABCC2—esophageal cancer	0.00044	0.111	CrCbGaD
Epirubicin—ABCC1—lymph node—esophageal cancer	0.00032	0.00838	CbGeAlD
Epirubicin—Daunorubicin—ABCB1—esophageal cancer	0.000199	0.0504	CrCbGaD
Epirubicin—Doxorubicin—ABCB1—esophageal cancer	0.000162	0.041	CrCbGaD
Epirubicin—Angina pectoris—Capecitabine—esophageal cancer	0.000125	0.000963	CcSEcCtD
Epirubicin—Arrhythmia—Cisplatin—esophageal cancer	0.000124	0.000959	CcSEcCtD
Epirubicin—Bronchitis—Capecitabine—esophageal cancer	0.000123	0.000951	CcSEcCtD
Epirubicin—Alopecia—Cisplatin—esophageal cancer	0.000123	0.000949	CcSEcCtD
Epirubicin—Hepatic failure—Methotrexate—esophageal cancer	0.000123	0.000947	CcSEcCtD
Epirubicin—Pancytopenia—Capecitabine—esophageal cancer	0.000122	0.000939	CcSEcCtD
Epirubicin—Erythema—Cisplatin—esophageal cancer	0.000121	0.000934	CcSEcCtD
Epirubicin—Malnutrition—Cisplatin—esophageal cancer	0.000121	0.000934	CcSEcCtD
Epirubicin—Dysuria—Capecitabine—esophageal cancer	0.00012	0.000924	CcSEcCtD
Epirubicin—Neutropenia—Capecitabine—esophageal cancer	0.00012	0.000924	CcSEcCtD
Epirubicin—Renal failure acute—Methotrexate—esophageal cancer	0.00012	0.000922	CcSEcCtD
Epirubicin—Flatulence—Cisplatin—esophageal cancer	0.000119	0.000921	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000119	0.000919	CcSEcCtD
Epirubicin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000117	0.000902	CcSEcCtD
Epirubicin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000117	0.000902	CcSEcCtD
Epirubicin—Weight increased—Capecitabine—esophageal cancer	0.000117	0.0009	CcSEcCtD
Epirubicin—Muscle spasms—Cisplatin—esophageal cancer	0.000116	0.000898	CcSEcCtD
Epirubicin—Weight decreased—Capecitabine—esophageal cancer	0.000116	0.000894	CcSEcCtD
Epirubicin—Hyperglycaemia—Capecitabine—esophageal cancer	0.000116	0.000892	CcSEcCtD
Epirubicin—Pneumonia—Capecitabine—esophageal cancer	0.000115	0.000887	CcSEcCtD
Epirubicin—Infestation NOS—Capecitabine—esophageal cancer	0.000114	0.000881	CcSEcCtD
Epirubicin—Infestation—Capecitabine—esophageal cancer	0.000114	0.000881	CcSEcCtD
Epirubicin—Vision blurred—Cisplatin—esophageal cancer	0.000114	0.000881	CcSEcCtD
Epirubicin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000114	0.00088	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000113	0.000874	CcSEcCtD
Epirubicin—Lethargy—Methotrexate—esophageal cancer	0.000113	0.000869	CcSEcCtD
Epirubicin—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000113	0.000869	CcSEcCtD
Epirubicin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000112	0.000867	CcSEcCtD
Epirubicin—Renal failure—Capecitabine—esophageal cancer	0.000112	0.000866	CcSEcCtD
Epirubicin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000112	0.000864	CcSEcCtD
Epirubicin—Anaemia—Cisplatin—esophageal cancer	0.000112	0.000864	CcSEcCtD
Epirubicin—Stomatitis—Capecitabine—esophageal cancer	0.000111	0.000859	CcSEcCtD
Epirubicin—Jaundice—Capecitabine—esophageal cancer	0.000111	0.000859	CcSEcCtD
Epirubicin—Conjunctivitis—Capecitabine—esophageal cancer	0.000111	0.000857	CcSEcCtD
Epirubicin—Urinary tract infection—Capecitabine—esophageal cancer	0.000111	0.000857	CcSEcCtD
Epirubicin—Osteoarthritis—Methotrexate—esophageal cancer	0.00011	0.000851	CcSEcCtD
Epirubicin—Malaise—Cisplatin—esophageal cancer	0.000109	0.000843	CcSEcCtD
Epirubicin—Haematuria—Capecitabine—esophageal cancer	0.000109	0.00084	CcSEcCtD
Epirubicin—Leukopenia—Cisplatin—esophageal cancer	0.000108	0.000836	CcSEcCtD
Epirubicin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000108	0.000834	CcSEcCtD
Epirubicin—Epistaxis—Capecitabine—esophageal cancer	0.000108	0.000831	CcSEcCtD
Epirubicin—Agranulocytosis—Capecitabine—esophageal cancer	0.000107	0.000823	CcSEcCtD
Epirubicin—Convulsion—Cisplatin—esophageal cancer	0.000105	0.00081	CcSEcCtD
Epirubicin—Mood swings—Methotrexate—esophageal cancer	0.000105	0.000807	CcSEcCtD
Epirubicin—Bradycardia—Capecitabine—esophageal cancer	0.000104	0.000805	CcSEcCtD
Epirubicin—Ataxia—Methotrexate—esophageal cancer	0.000104	0.000801	CcSEcCtD
Epirubicin—Myalgia—Cisplatin—esophageal cancer	0.000103	0.000795	CcSEcCtD
Epirubicin—Haemoglobin—Capecitabine—esophageal cancer	0.000103	0.000795	CcSEcCtD
Epirubicin—Rhinitis—Capecitabine—esophageal cancer	0.000103	0.000793	CcSEcCtD
Epirubicin—Anxiety—Cisplatin—esophageal cancer	0.000103	0.000793	CcSEcCtD
Epirubicin—Haemorrhage—Capecitabine—esophageal cancer	0.000103	0.000791	CcSEcCtD
Epirubicin—Hepatitis—Capecitabine—esophageal cancer	0.000103	0.000791	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000102	0.00079	CcSEcCtD
Epirubicin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000102	0.000787	CcSEcCtD
Epirubicin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000102	0.000786	CcSEcCtD
Epirubicin—Discomfort—Cisplatin—esophageal cancer	0.000102	0.000786	CcSEcCtD
Epirubicin—Pharyngitis—Capecitabine—esophageal cancer	0.000102	0.000785	CcSEcCtD
Epirubicin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000101	0.000781	CcSEcCtD
Epirubicin—Oedema peripheral—Capecitabine—esophageal cancer	0.000101	0.000779	CcSEcCtD
Epirubicin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000101	0.000778	CcSEcCtD
Epirubicin—Urethral disorder—Capecitabine—esophageal cancer	0.000101	0.000776	CcSEcCtD
Epirubicin—Breast disorder—Methotrexate—esophageal cancer	9.97e-05	0.000769	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	9.94e-05	0.000767	CcSEcCtD
Epirubicin—Anaphylactic shock—Cisplatin—esophageal cancer	9.88e-05	0.000763	CcSEcCtD
Epirubicin—Oedema—Cisplatin—esophageal cancer	9.88e-05	0.000763	CcSEcCtD
Epirubicin—Visual impairment—Capecitabine—esophageal cancer	9.88e-05	0.000763	CcSEcCtD
Epirubicin—Infection—Cisplatin—esophageal cancer	9.82e-05	0.000758	CcSEcCtD
Epirubicin—Erythema multiforme—Capecitabine—esophageal cancer	9.7e-05	0.000748	CcSEcCtD
Epirubicin—Nervous system disorder—Cisplatin—esophageal cancer	9.69e-05	0.000748	CcSEcCtD
Epirubicin—Thrombocytopenia—Cisplatin—esophageal cancer	9.68e-05	0.000747	CcSEcCtD
Epirubicin—Tachycardia—Cisplatin—esophageal cancer	9.65e-05	0.000744	CcSEcCtD
Epirubicin—Skin disorder—Cisplatin—esophageal cancer	9.6e-05	0.000741	CcSEcCtD
Epirubicin—Eye disorder—Capecitabine—esophageal cancer	9.58e-05	0.000739	CcSEcCtD
Epirubicin—Tinnitus—Capecitabine—esophageal cancer	9.56e-05	0.000738	CcSEcCtD
Epirubicin—Hyperhidrosis—Cisplatin—esophageal cancer	9.55e-05	0.000737	CcSEcCtD
Epirubicin—Asthma—Methotrexate—esophageal cancer	9.54e-05	0.000736	CcSEcCtD
Epirubicin—Cardiac disorder—Capecitabine—esophageal cancer	9.52e-05	0.000734	CcSEcCtD
Epirubicin—Flushing—Capecitabine—esophageal cancer	9.52e-05	0.000734	CcSEcCtD
Epirubicin—Eosinophilia—Methotrexate—esophageal cancer	9.44e-05	0.000729	CcSEcCtD
Epirubicin—Anorexia—Cisplatin—esophageal cancer	9.42e-05	0.000727	CcSEcCtD
Epirubicin—Pancreatitis—Methotrexate—esophageal cancer	9.35e-05	0.000721	CcSEcCtD
Epirubicin—Angiopathy—Capecitabine—esophageal cancer	9.3e-05	0.000718	CcSEcCtD
Epirubicin—Immune system disorder—Capecitabine—esophageal cancer	9.26e-05	0.000715	CcSEcCtD
Epirubicin—Mediastinal disorder—Capecitabine—esophageal cancer	9.24e-05	0.000713	CcSEcCtD
Epirubicin—Hypotension—Cisplatin—esophageal cancer	9.24e-05	0.000713	CcSEcCtD
Epirubicin—Chills—Capecitabine—esophageal cancer	9.2e-05	0.00071	CcSEcCtD
Epirubicin—Arrhythmia—Capecitabine—esophageal cancer	9.16e-05	0.000707	CcSEcCtD
Epirubicin—Alopecia—Capecitabine—esophageal cancer	9.06e-05	0.000699	CcSEcCtD
Epirubicin—Pancytopenia—Methotrexate—esophageal cancer	9.06e-05	0.000699	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	9e-05	0.000695	CcSEcCtD
Epirubicin—Mental disorder—Capecitabine—esophageal cancer	8.98e-05	0.000693	CcSEcCtD
Epirubicin—Erythema—Capecitabine—esophageal cancer	8.93e-05	0.000689	CcSEcCtD
Epirubicin—Malnutrition—Capecitabine—esophageal cancer	8.93e-05	0.000689	CcSEcCtD
Epirubicin—Dysuria—Methotrexate—esophageal cancer	8.92e-05	0.000688	CcSEcCtD
Epirubicin—Neutropenia—Methotrexate—esophageal cancer	8.92e-05	0.000688	CcSEcCtD
Epirubicin—Paraesthesia—Cisplatin—esophageal cancer	8.87e-05	0.000685	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Methotrexate—esophageal cancer	8.86e-05	0.000684	CcSEcCtD
Epirubicin—Dyspnoea—Cisplatin—esophageal cancer	8.81e-05	0.00068	CcSEcCtD
Epirubicin—Flatulence—Capecitabine—esophageal cancer	8.8e-05	0.000679	CcSEcCtD
Epirubicin—Dysgeusia—Capecitabine—esophageal cancer	8.74e-05	0.000675	CcSEcCtD
Epirubicin—Photosensitivity reaction—Methotrexate—esophageal cancer	8.71e-05	0.000672	CcSEcCtD
Epirubicin—Back pain—Capecitabine—esophageal cancer	8.63e-05	0.000666	CcSEcCtD
Epirubicin—Decreased appetite—Cisplatin—esophageal cancer	8.59e-05	0.000663	CcSEcCtD
Epirubicin—Muscle spasms—Capecitabine—esophageal cancer	8.58e-05	0.000662	CcSEcCtD
Epirubicin—Pneumonia—Methotrexate—esophageal cancer	8.55e-05	0.00066	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Cisplatin—esophageal cancer	8.53e-05	0.000658	CcSEcCtD
Epirubicin—Infestation NOS—Methotrexate—esophageal cancer	8.5e-05	0.000656	CcSEcCtD
Epirubicin—Drowsiness—Methotrexate—esophageal cancer	8.5e-05	0.000656	CcSEcCtD
Epirubicin—Infestation—Methotrexate—esophageal cancer	8.5e-05	0.000656	CcSEcCtD
Epirubicin—Pain—Cisplatin—esophageal cancer	8.45e-05	0.000652	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	8.43e-05	0.00065	CcSEcCtD
Epirubicin—Vision blurred—Capecitabine—esophageal cancer	8.41e-05	0.000649	CcSEcCtD
Epirubicin—Renal failure—Methotrexate—esophageal cancer	8.36e-05	0.000645	CcSEcCtD
Epirubicin—Stomatitis—Methotrexate—esophageal cancer	8.29e-05	0.00064	CcSEcCtD
Epirubicin—Ill-defined disorder—Capecitabine—esophageal cancer	8.28e-05	0.000639	CcSEcCtD
Epirubicin—Conjunctivitis—Methotrexate—esophageal cancer	8.27e-05	0.000638	CcSEcCtD
Epirubicin—Anaemia—Capecitabine—esophageal cancer	8.25e-05	0.000637	CcSEcCtD
Epirubicin—Sweating—Methotrexate—esophageal cancer	8.15e-05	0.000629	CcSEcCtD
Epirubicin—Feeling abnormal—Cisplatin—esophageal cancer	8.14e-05	0.000628	CcSEcCtD
Epirubicin—Haematuria—Methotrexate—esophageal cancer	8.11e-05	0.000626	CcSEcCtD
Epirubicin—Malaise—Capecitabine—esophageal cancer	8.05e-05	0.000621	CcSEcCtD
Epirubicin—Hepatobiliary disease—Methotrexate—esophageal cancer	8.04e-05	0.000621	CcSEcCtD
Epirubicin—Epistaxis—Methotrexate—esophageal cancer	8.02e-05	0.000619	CcSEcCtD
Epirubicin—Vertigo—Capecitabine—esophageal cancer	8.02e-05	0.000619	CcSEcCtD
Epirubicin—Syncope—Capecitabine—esophageal cancer	8.01e-05	0.000618	CcSEcCtD
Epirubicin—Leukopenia—Capecitabine—esophageal cancer	7.99e-05	0.000617	CcSEcCtD
Epirubicin—Agranulocytosis—Methotrexate—esophageal cancer	7.94e-05	0.000612	CcSEcCtD
Epirubicin—Palpitations—Capecitabine—esophageal cancer	7.89e-05	0.000609	CcSEcCtD
Epirubicin—Loss of consciousness—Capecitabine—esophageal cancer	7.85e-05	0.000605	CcSEcCtD
Epirubicin—Body temperature increased—Cisplatin—esophageal cancer	7.81e-05	0.000603	CcSEcCtD
Epirubicin—Cough—Capecitabine—esophageal cancer	7.79e-05	0.000601	CcSEcCtD
Epirubicin—Hypertension—Capecitabine—esophageal cancer	7.71e-05	0.000595	CcSEcCtD
Epirubicin—Haemoglobin—Methotrexate—esophageal cancer	7.67e-05	0.000592	CcSEcCtD
Epirubicin—Haemorrhage—Methotrexate—esophageal cancer	7.63e-05	0.000589	CcSEcCtD
Epirubicin—Hepatitis—Methotrexate—esophageal cancer	7.63e-05	0.000589	CcSEcCtD
Epirubicin—Arthralgia—Capecitabine—esophageal cancer	7.6e-05	0.000586	CcSEcCtD
Epirubicin—Chest pain—Capecitabine—esophageal cancer	7.6e-05	0.000586	CcSEcCtD
Epirubicin—Myalgia—Capecitabine—esophageal cancer	7.6e-05	0.000586	CcSEcCtD
Epirubicin—Pharyngitis—Methotrexate—esophageal cancer	7.58e-05	0.000585	CcSEcCtD
Epirubicin—Anxiety—Capecitabine—esophageal cancer	7.57e-05	0.000584	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	7.55e-05	0.000582	CcSEcCtD
Epirubicin—Urinary tract disorder—Methotrexate—esophageal cancer	7.54e-05	0.000582	CcSEcCtD
Epirubicin—Discomfort—Capecitabine—esophageal cancer	7.51e-05	0.000579	CcSEcCtD
Epirubicin—Urethral disorder—Methotrexate—esophageal cancer	7.48e-05	0.000577	CcSEcCtD
Epirubicin—Dry mouth—Capecitabine—esophageal cancer	7.43e-05	0.000573	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—esophageal cancer	7.36e-05	0.000568	CcSEcCtD
Epirubicin—Confusional state—Capecitabine—esophageal cancer	7.35e-05	0.000567	CcSEcCtD
Epirubicin—Oedema—Capecitabine—esophageal cancer	7.29e-05	0.000562	CcSEcCtD
Epirubicin—Hypersensitivity—Cisplatin—esophageal cancer	7.28e-05	0.000562	CcSEcCtD
Epirubicin—Infection—Capecitabine—esophageal cancer	7.24e-05	0.000558	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—esophageal cancer	7.22e-05	0.000557	CcSEcCtD
Epirubicin—Shock—Capecitabine—esophageal cancer	7.17e-05	0.000553	CcSEcCtD
Epirubicin—Nervous system disorder—Capecitabine—esophageal cancer	7.14e-05	0.000551	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—esophageal cancer	7.13e-05	0.00055	CcSEcCtD
Epirubicin—Thrombocytopenia—Capecitabine—esophageal cancer	7.13e-05	0.00055	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—esophageal cancer	7.12e-05	0.000549	CcSEcCtD
Epirubicin—Tachycardia—Capecitabine—esophageal cancer	7.11e-05	0.000549	CcSEcCtD
Epirubicin—Asthenia—Cisplatin—esophageal cancer	7.09e-05	0.000547	CcSEcCtD
Epirubicin—Cardiac disorder—Methotrexate—esophageal cancer	7.08e-05	0.000547	CcSEcCtD
Epirubicin—Skin disorder—Capecitabine—esophageal cancer	7.08e-05	0.000546	CcSEcCtD
Epirubicin—Hyperhidrosis—Capecitabine—esophageal cancer	7.04e-05	0.000543	CcSEcCtD
Epirubicin—Anorexia—Capecitabine—esophageal cancer	6.94e-05	0.000536	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—esophageal cancer	6.93e-05	0.000534	CcSEcCtD
Epirubicin—Immune system disorder—Methotrexate—esophageal cancer	6.9e-05	0.000532	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—esophageal cancer	6.88e-05	0.000531	CcSEcCtD
Epirubicin—Chills—Methotrexate—esophageal cancer	6.85e-05	0.000529	CcSEcCtD
Epirubicin—Hypotension—Capecitabine—esophageal cancer	6.81e-05	0.000525	CcSEcCtD
Epirubicin—Diarrhoea—Cisplatin—esophageal cancer	6.76e-05	0.000522	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—esophageal cancer	6.75e-05	0.00052	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—esophageal cancer	6.69e-05	0.000516	CcSEcCtD
Epirubicin—Erythema—Methotrexate—esophageal cancer	6.65e-05	0.000513	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—esophageal cancer	6.65e-05	0.000513	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	6.64e-05	0.000512	CcSEcCtD
Epirubicin—Insomnia—Capecitabine—esophageal cancer	6.59e-05	0.000508	CcSEcCtD
Epirubicin—Paraesthesia—Capecitabine—esophageal cancer	6.54e-05	0.000505	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—esophageal cancer	6.51e-05	0.000502	CcSEcCtD
Epirubicin—Dyspnoea—Capecitabine—esophageal cancer	6.5e-05	0.000501	CcSEcCtD
Epirubicin—Back pain—Methotrexate—esophageal cancer	6.43e-05	0.000496	CcSEcCtD
Epirubicin—Dyspepsia—Capecitabine—esophageal cancer	6.41e-05	0.000495	CcSEcCtD
Epirubicin—Decreased appetite—Capecitabine—esophageal cancer	6.33e-05	0.000489	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Capecitabine—esophageal cancer	6.29e-05	0.000485	CcSEcCtD
Epirubicin—Vomiting—Cisplatin—esophageal cancer	6.28e-05	0.000485	CcSEcCtD
Epirubicin—Fatigue—Capecitabine—esophageal cancer	6.28e-05	0.000485	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—esophageal cancer	6.26e-05	0.000483	CcSEcCtD
Epirubicin—Rash—Cisplatin—esophageal cancer	6.23e-05	0.000481	CcSEcCtD
Epirubicin—Pain—Capecitabine—esophageal cancer	6.23e-05	0.000481	CcSEcCtD
Epirubicin—Constipation—Capecitabine—esophageal cancer	6.23e-05	0.000481	CcSEcCtD
Epirubicin—Dermatitis—Cisplatin—esophageal cancer	6.23e-05	0.00048	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—esophageal cancer	6.17e-05	0.000476	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—esophageal cancer	6.14e-05	0.000474	CcSEcCtD
Epirubicin—Feeling abnormal—Capecitabine—esophageal cancer	6e-05	0.000463	CcSEcCtD
Epirubicin—Malaise—Methotrexate—esophageal cancer	5.99e-05	0.000462	CcSEcCtD
Epirubicin—Vertigo—Methotrexate—esophageal cancer	5.97e-05	0.000461	CcSEcCtD
Epirubicin—Gastrointestinal pain—Capecitabine—esophageal cancer	5.96e-05	0.00046	CcSEcCtD
Epirubicin—Leukopenia—Methotrexate—esophageal cancer	5.95e-05	0.000459	CcSEcCtD
Epirubicin—Nausea—Cisplatin—esophageal cancer	5.87e-05	0.000453	CcSEcCtD
Epirubicin—Cough—Methotrexate—esophageal cancer	5.8e-05	0.000447	CcSEcCtD
Epirubicin—Urticaria—Capecitabine—esophageal cancer	5.79e-05	0.000447	CcSEcCtD
Epirubicin—Abdominal pain—Capecitabine—esophageal cancer	5.76e-05	0.000444	CcSEcCtD
Epirubicin—Body temperature increased—Capecitabine—esophageal cancer	5.76e-05	0.000444	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—esophageal cancer	5.76e-05	0.000444	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—esophageal cancer	5.66e-05	0.000437	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—esophageal cancer	5.66e-05	0.000437	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—esophageal cancer	5.66e-05	0.000437	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	5.62e-05	0.000434	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—esophageal cancer	5.59e-05	0.000431	CcSEcCtD
Epirubicin—Confusional state—Methotrexate—esophageal cancer	5.47e-05	0.000422	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—esophageal cancer	5.42e-05	0.000418	CcSEcCtD
Epirubicin—Infection—Methotrexate—esophageal cancer	5.39e-05	0.000416	CcSEcCtD
Epirubicin—Hypersensitivity—Capecitabine—esophageal cancer	5.37e-05	0.000414	CcSEcCtD
Epirubicin—Nervous system disorder—Methotrexate—esophageal cancer	5.32e-05	0.00041	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—esophageal cancer	5.31e-05	0.00041	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—esophageal cancer	5.27e-05	0.000406	CcSEcCtD
Epirubicin—Hyperhidrosis—Methotrexate—esophageal cancer	5.24e-05	0.000405	CcSEcCtD
Epirubicin—Asthenia—Capecitabine—esophageal cancer	5.23e-05	0.000403	CcSEcCtD
Epirubicin—Anorexia—Methotrexate—esophageal cancer	5.17e-05	0.000399	CcSEcCtD
Epirubicin—Pruritus—Capecitabine—esophageal cancer	5.15e-05	0.000398	CcSEcCtD
Epirubicin—Hypotension—Methotrexate—esophageal cancer	5.07e-05	0.000391	CcSEcCtD
Epirubicin—Diarrhoea—Capecitabine—esophageal cancer	4.98e-05	0.000385	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	4.94e-05	0.000381	CcSEcCtD
Epirubicin—Insomnia—Methotrexate—esophageal cancer	4.91e-05	0.000378	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—esophageal cancer	4.87e-05	0.000376	CcSEcCtD
Epirubicin—Dyspnoea—Methotrexate—esophageal cancer	4.84e-05	0.000373	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—esophageal cancer	4.82e-05	0.000372	CcSEcCtD
Epirubicin—Dizziness—Capecitabine—esophageal cancer	4.82e-05	0.000372	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—esophageal cancer	4.77e-05	0.000368	CcSEcCtD
Epirubicin—Decreased appetite—Methotrexate—esophageal cancer	4.71e-05	0.000364	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Methotrexate—esophageal cancer	4.68e-05	0.000361	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—esophageal cancer	4.68e-05	0.000361	CcSEcCtD
Epirubicin—Pain—Methotrexate—esophageal cancer	4.64e-05	0.000358	CcSEcCtD
Epirubicin—Vomiting—Capecitabine—esophageal cancer	4.63e-05	0.000357	CcSEcCtD
Epirubicin—Rash—Capecitabine—esophageal cancer	4.59e-05	0.000354	CcSEcCtD
Epirubicin—Dermatitis—Capecitabine—esophageal cancer	4.59e-05	0.000354	CcSEcCtD
Epirubicin—Headache—Capecitabine—esophageal cancer	4.56e-05	0.000352	CcSEcCtD
Epirubicin—Feeling abnormal—Methotrexate—esophageal cancer	4.47e-05	0.000345	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methotrexate—esophageal cancer	4.43e-05	0.000342	CcSEcCtD
Epirubicin—Nausea—Capecitabine—esophageal cancer	4.33e-05	0.000334	CcSEcCtD
Epirubicin—Urticaria—Methotrexate—esophageal cancer	4.31e-05	0.000332	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—esophageal cancer	4.29e-05	0.000331	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—esophageal cancer	4.29e-05	0.000331	CcSEcCtD
Epirubicin—Hypersensitivity—Methotrexate—esophageal cancer	4e-05	0.000308	CcSEcCtD
Epirubicin—Asthenia—Methotrexate—esophageal cancer	3.89e-05	0.0003	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—esophageal cancer	3.84e-05	0.000296	CcSEcCtD
Epirubicin—Diarrhoea—Methotrexate—esophageal cancer	3.71e-05	0.000286	CcSEcCtD
Epirubicin—ABCC1—Metabolism—BLVRB—esophageal cancer	3.7e-05	0.000394	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC52A3—esophageal cancer	3.7e-05	0.000394	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KMT2D—esophageal cancer	3.7e-05	0.000393	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—RB1—esophageal cancer	3.69e-05	0.000393	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CA2—esophageal cancer	3.67e-05	0.000391	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.65e-05	0.000388	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CCND1—esophageal cancer	3.62e-05	0.000385	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CA2—esophageal cancer	3.6e-05	0.000383	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKAP13—esophageal cancer	3.59e-05	0.000382	CbGpPWpGaD
Epirubicin—Dizziness—Methotrexate—esophageal cancer	3.59e-05	0.000277	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.52e-05	0.000375	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	3.5e-05	0.000373	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	3.5e-05	0.000373	CbGpPWpGaD
Epirubicin—Vomiting—Methotrexate—esophageal cancer	3.45e-05	0.000266	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.43e-05	0.000365	CbGpPWpGaD
Epirubicin—Rash—Methotrexate—esophageal cancer	3.42e-05	0.000264	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—esophageal cancer	3.42e-05	0.000264	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ADH7—esophageal cancer	3.42e-05	0.000363	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PLCE1—esophageal cancer	3.42e-05	0.000363	CbGpPWpGaD
Epirubicin—Headache—Methotrexate—esophageal cancer	3.4e-05	0.000262	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ADH7—esophageal cancer	3.35e-05	0.000356	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PLCE1—esophageal cancer	3.35e-05	0.000356	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—EP300—esophageal cancer	3.33e-05	0.000355	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.32e-05	0.000353	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.31e-05	0.000352	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.31e-05	0.000352	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—RB1—esophageal cancer	3.3e-05	0.000352	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADCYAP1—esophageal cancer	3.29e-05	0.00035	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ABL1—esophageal cancer	3.29e-05	0.00035	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PDE4D—esophageal cancer	3.29e-05	0.00035	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—esophageal cancer	3.28e-05	0.000349	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FKBP1A—esophageal cancer	3.27e-05	0.000348	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	3.25e-05	0.000346	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CCND1—esophageal cancer	3.24e-05	0.000344	CbGpPWpGaD
Epirubicin—Nausea—Methotrexate—esophageal cancer	3.22e-05	0.000249	CcSEcCtD
Epirubicin—ABCC1—Disease—WIF1—esophageal cancer	3.2e-05	0.00034	CbGpPWpGaD
Epirubicin—ABCC1—Disease—DOCK2—esophageal cancer	3.2e-05	0.00034	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.18e-05	0.000338	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.16e-05	0.000336	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC10A2—esophageal cancer	3.15e-05	0.000335	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CA1—esophageal cancer	3.15e-05	0.000335	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN1A—esophageal cancer	3.13e-05	0.000333	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNG7—esophageal cancer	3.13e-05	0.000333	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.11e-05	0.000331	CbGpPWpGaD
Epirubicin—PLA2G4A—Phospholipid metabolism—PIK3CA—esophageal cancer	3.03e-05	0.000323	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—WWOX—esophageal cancer	3.01e-05	0.000321	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ADH1B—esophageal cancer	2.99e-05	0.000319	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—EP300—esophageal cancer	2.98e-05	0.000317	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CSNK1A1—esophageal cancer	2.95e-05	0.000314	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADH1B—esophageal cancer	2.94e-05	0.000313	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MYC—esophageal cancer	2.9e-05	0.000309	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—esophageal cancer	2.9e-05	0.000309	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.88e-05	0.000307	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CA2—esophageal cancer	2.88e-05	0.000306	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FKBP1A—esophageal cancer	2.87e-05	0.000305	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TYMP—esophageal cancer	2.86e-05	0.000305	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.81e-05	0.000299	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TYMP—esophageal cancer	2.81e-05	0.000299	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—WIF1—esophageal cancer	2.8e-05	0.000298	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP26A1—esophageal cancer	2.78e-05	0.000296	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.75e-05	0.000293	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL2—esophageal cancer	2.75e-05	0.000293	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CCND1—esophageal cancer	2.74e-05	0.000292	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP26A1—esophageal cancer	2.73e-05	0.000291	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALOX15—esophageal cancer	2.71e-05	0.000289	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.7e-05	0.000287	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.69e-05	0.000287	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADH7—esophageal cancer	2.68e-05	0.000285	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PLCE1—esophageal cancer	2.68e-05	0.000285	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALOX15—esophageal cancer	2.66e-05	0.000283	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	2.65e-05	0.000282	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.65e-05	0.000281	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.61e-05	0.000278	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—esophageal cancer	2.6e-05	0.000276	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TPI1—esophageal cancer	2.59e-05	0.000275	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTO1—esophageal cancer	2.59e-05	0.000275	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CSNK1A1—esophageal cancer	2.58e-05	0.000275	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	2.58e-05	0.000275	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ANXA1—esophageal cancer	2.56e-05	0.000272	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CREBBP—esophageal cancer	2.55e-05	0.000271	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TPI1—esophageal cancer	2.54e-05	0.00027	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTO1—esophageal cancer	2.54e-05	0.00027	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—EP300—esophageal cancer	2.53e-05	0.000269	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	2.51e-05	0.000267	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—SST—esophageal cancer	2.49e-05	0.000265	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALDOB—esophageal cancer	2.48e-05	0.000264	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ELMO1—esophageal cancer	2.48e-05	0.000264	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CCND1—esophageal cancer	2.45e-05	0.000261	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALDOB—esophageal cancer	2.43e-05	0.000259	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GHRL—esophageal cancer	2.43e-05	0.000258	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GSTO1—esophageal cancer	2.42e-05	0.000258	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TPI1—esophageal cancer	2.42e-05	0.000258	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PFN1—esophageal cancer	2.42e-05	0.000257	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GAPDH—esophageal cancer	2.39e-05	0.000254	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—esophageal cancer	2.37e-05	0.000253	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS2—esophageal cancer	2.37e-05	0.000252	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CRABP1—esophageal cancer	2.37e-05	0.000252	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADH1B—esophageal cancer	2.35e-05	0.00025	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GAPDH—esophageal cancer	2.34e-05	0.000249	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.34e-05	0.000249	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ALDOB—esophageal cancer	2.32e-05	0.000247	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CRABP1—esophageal cancer	2.32e-05	0.000247	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—RB1—esophageal cancer	2.31e-05	0.000246	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.3e-05	0.000244	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NOS3—esophageal cancer	2.28e-05	0.000243	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	2.27e-05	0.000242	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.26e-05	0.000241	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—EP300—esophageal cancer	2.26e-05	0.00024	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNG7—esophageal cancer	2.25e-05	0.00024	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TYMP—esophageal cancer	2.24e-05	0.000239	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIST1H2BM—esophageal cancer	2.23e-05	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GAPDH—esophageal cancer	2.23e-05	0.000238	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNG7—esophageal cancer	2.21e-05	0.000235	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.2e-05	0.000234	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—esophageal cancer	2.2e-05	0.000234	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP26A1—esophageal cancer	2.18e-05	0.000232	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ELMO1—esophageal cancer	2.17e-05	0.000231	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—esophageal cancer	2.13e-05	0.000227	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CREBBP—esophageal cancer	2.13e-05	0.000227	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALOX15—esophageal cancer	2.13e-05	0.000226	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKAP13—esophageal cancer	2.12e-05	0.000226	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALDH2—esophageal cancer	2.11e-05	0.000225	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTGS2—esophageal cancer	2.09e-05	0.000222	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.08e-05	0.000221	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALDH2—esophageal cancer	2.07e-05	0.00022	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	2.03e-05	0.000216	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTO1—esophageal cancer	2.03e-05	0.000216	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TPI1—esophageal cancer	2.03e-05	0.000216	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—esophageal cancer	2.01e-05	0.000214	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2A6—esophageal cancer	1.98e-05	0.000211	CbGpPWpGaD
Epirubicin—ABCC1—Disease—XIAP—esophageal cancer	1.97e-05	0.00021	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTT1—esophageal cancer	1.97e-05	0.000209	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—esophageal cancer	1.97e-05	0.000209	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIST1H2BM—esophageal cancer	1.96e-05	0.000208	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP2A6—esophageal cancer	1.95e-05	0.000207	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALDOB—esophageal cancer	1.94e-05	0.000207	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDE4D—esophageal cancer	1.94e-05	0.000207	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.94e-05	0.000206	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	1.92e-05	0.000204	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS3—esophageal cancer	1.91e-05	0.000203	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ENO1—esophageal cancer	1.88e-05	0.0002	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS1—esophageal cancer	1.88e-05	0.0002	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GAPDH—esophageal cancer	1.87e-05	0.000199	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	1.86e-05	0.000198	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CRABP1—esophageal cancer	1.85e-05	0.000197	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSME1—esophageal cancer	1.85e-05	0.000197	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSME2—esophageal cancer	1.85e-05	0.000197	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNG7—esophageal cancer	1.85e-05	0.000196	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ENO1—esophageal cancer	1.84e-05	0.000196	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS1—esophageal cancer	1.84e-05	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Disease—B2M—esophageal cancer	1.84e-05	0.000195	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSME2—esophageal cancer	1.82e-05	0.000193	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSME1—esophageal cancer	1.82e-05	0.000193	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	1.77e-05	0.000188	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNG7—esophageal cancer	1.76e-05	0.000188	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ENO1—esophageal cancer	1.76e-05	0.000187	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—EP300—esophageal cancer	1.74e-05	0.000185	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSME2—esophageal cancer	1.73e-05	0.000184	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSME1—esophageal cancer	1.73e-05	0.000184	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—XIAP—esophageal cancer	1.73e-05	0.000184	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—esophageal cancer	1.72e-05	0.000183	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CALR—esophageal cancer	1.66e-05	0.000177	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	1.66e-05	0.000177	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALDH2—esophageal cancer	1.65e-05	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNA1—esophageal cancer	1.64e-05	0.000174	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL2—esophageal cancer	1.63e-05	0.000173	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—esophageal cancer	1.62e-05	0.000172	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FBXW7—esophageal cancer	1.61e-05	0.000171	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1B1—esophageal cancer	1.6e-05	0.00017	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.59e-05	0.000169	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—EP300—esophageal cancer	1.58e-05	0.000168	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—esophageal cancer	1.57e-05	0.000167	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1B1—esophageal cancer	1.57e-05	0.000167	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2A6—esophageal cancer	1.55e-05	0.000165	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.55e-05	0.000165	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	1.54e-05	0.000164	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSME1—esophageal cancer	1.52e-05	0.000162	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSME2—esophageal cancer	1.52e-05	0.000162	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ANXA1—esophageal cancer	1.51e-05	0.000161	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP19A1—esophageal cancer	1.5e-05	0.00016	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP19A1—esophageal cancer	1.47e-05	0.000157	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ENO1—esophageal cancer	1.47e-05	0.000157	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS1—esophageal cancer	1.47e-05	0.000157	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.47e-05	0.000157	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SST—esophageal cancer	1.47e-05	0.000157	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSME1—esophageal cancer	1.45e-05	0.000155	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSME2—esophageal cancer	1.45e-05	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—EP300—esophageal cancer	1.45e-05	0.000154	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH3—esophageal cancer	1.43e-05	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GHRL—esophageal cancer	1.43e-05	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FBXW7—esophageal cancer	1.41e-05	0.00015	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—esophageal cancer	1.38e-05	0.000146	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—esophageal cancer	1.37e-05	0.000146	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—esophageal cancer	1.35e-05	0.000143	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.32e-05	0.00014	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCB1—esophageal cancer	1.32e-05	0.00014	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFBR2—esophageal cancer	1.3e-05	0.000138	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCB1—esophageal cancer	1.29e-05	0.000137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH2—esophageal cancer	1.29e-05	0.000137	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—esophageal cancer	1.28e-05	0.000137	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.27e-05	0.000135	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1B1—esophageal cancer	1.25e-05	0.000133	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SMAD4—esophageal cancer	1.23e-05	0.000131	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP19A1—esophageal cancer	1.18e-05	0.000125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFBR2—esophageal cancer	1.14e-05	0.000121	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—esophageal cancer	1.13e-05	0.00012	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SMAD4—esophageal cancer	1.08e-05	0.000115	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—esophageal cancer	1.07e-05	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—esophageal cancer	1.07e-05	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.05e-05	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—esophageal cancer	1.04e-05	0.00011	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCB1—esophageal cancer	1.03e-05	0.00011	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIF1A—esophageal cancer	1.01e-05	0.000107	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.76e-06	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—esophageal cancer	9.17e-06	9.76e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOTCH1—esophageal cancer	9.08e-06	9.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIF1A—esophageal cancer	8.83e-06	9.4e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CREBBP—esophageal cancer	8.8e-06	9.36e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CREBBP—esophageal cancer	8.63e-06	9.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KDR—esophageal cancer	8.45e-06	8.99e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CREBBP—esophageal cancer	8.23e-06	8.76e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH1—esophageal cancer	7.96e-06	8.47e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—esophageal cancer	7.88e-06	8.38e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.8e-06	8.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—esophageal cancer	7.73e-06	8.22e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—esophageal cancer	7.37e-06	7.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CREBBP—esophageal cancer	7.22e-06	7.68e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—esophageal cancer	7.21e-06	7.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—esophageal cancer	7.09e-06	7.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—esophageal cancer	7.07e-06	7.52e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CREBBP—esophageal cancer	6.9e-06	7.34e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB2—esophageal cancer	6.9e-06	7.34e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—esophageal cancer	6.74e-06	7.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—esophageal cancer	6.46e-06	6.88e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—esophageal cancer	6.17e-06	6.57e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—esophageal cancer	6.15e-06	6.55e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB2—esophageal cancer	6.04e-06	6.43e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—EP300—esophageal cancer	5.99e-06	6.38e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1A—esophageal cancer	5.89e-06	6.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—EP300—esophageal cancer	5.88e-06	6.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—esophageal cancer	5.65e-06	6.01e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EP300—esophageal cancer	5.61e-06	5.97e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—esophageal cancer	5.34e-06	5.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1A—esophageal cancer	5.17e-06	5.5e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EP300—esophageal cancer	4.91e-06	5.23e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—esophageal cancer	4.89e-06	5.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—esophageal cancer	4.78e-06	5.09e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—EP300—esophageal cancer	4.7e-06	5e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—esophageal cancer	4.43e-06	4.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—esophageal cancer	4.35e-06	4.63e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—esophageal cancer	4.28e-06	4.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—esophageal cancer	4.19e-06	4.46e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—esophageal cancer	4.15e-06	4.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—esophageal cancer	3.64e-06	3.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—esophageal cancer	3.52e-06	3.74e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—esophageal cancer	3.47e-06	3.7e-05	CbGpPWpGaD
